With Capital Scarce, Charities Emerge As A Stronger Force On Start-Up Scene
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Disease charities are traditionally big funders of basic research. But those foundations are increasingly spawning specialized funds aimed at helping start-ups drive their candidates into later stages of development, where they might represent more attractive investment opportunities for pharmaceutical partners.